PATH and Impact Global Health R&D Blindspots Policy Series
The R&D Blindspots Policy Series is a collaborative collection of industry snapshot reports developed by PATH and Impact Global Health to inform policy, funding, and strategic decision-making in global health research and development. With a dedicated focus on Africa, the series identifies critical gaps, emerging priorities, and investment opportunities across the health innovation ecosystem, helping stakeholders direct resources where they are needed most.
Africa has articulated a clear and ambitious vision for health security and sovereignty—one that emphasises self‑reliance, resilient innovation systems, and the capacity to prevent, detect, and respond to health threats. At the same time, global health R&D continues to be shaped by epidemic risk, market incentives, and external priorities.
The R&D Blindspots Policy Series sits at this intersection, providing a set of industry snapshot analyses that translate complex R&D data into clear, actionable insights. The series takes a full value‑chain perspective, examining upstream research and clinical development alongside regulatory systems and manufacturing capacity, through an explicitly Africa‑centered lens grounded in continental priorities and disease burden. Together, these insights are intended to inform policy choices, investment decisions, and institutional reform across Africa’s health R&D ecosystem.
Rather than comprehensive reviews, each publication is designed as a focused diagnostic highlighting where systems are working, where gaps persist, and what is required to translate ambition into operational capability.
About the series
-
July 15, 2026The diagnostics deficit: Funding, access, and preparedness gaps in African health systems
-
May 4, 2026From commitment to capability: Are current R&D trends delivering on Africa’s health sovereignty ambitions?
-
March 2025Strengthening Africa’s mpox diagnostic capacity for enhanced epidemic preparedness and response